Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison

Infection Control and Hospital Epidemiology

Volumn 29, Issue 3, 2008, Pages 203-211

  MacDougall, Conan ^a   Polk, Ronald E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CARBAPENEM; CEFAZOLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; GATIFLOXACIN; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL BED CAPACITY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL; MULTIVARIATE ANALYSIS; PNEUMONIA; QUALITY CONTROL; RANDOMIZATION; RETROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT DURATION; UNITED STATES; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK ADJUSTMENT; RISK FACTORS; UNITED STATES;

EID: 39449119243     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/528810     Document Type: Article

References (42)

1. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5:1033-1048.
2. Interagency Task Force on Antimicrobial Resistance. A public health action plan to combat antimicrobial resistance. Part I. Domestic issues. Atlanta, GA: Centers for Disease Control and Prevention, 2001.
3. Avorn J, Barrett JF, Davey PG, McEwen SA, O'Brien TF, Levy SB. Antibiotic resistance: synthesis of recommendations by expert policy groups: a background document for the global strategy for containment of antimicrobial resistance. Boston, MA: Alliance for the Prudent Use of Antibiotics, 2001.
4. Guillemot D. Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 1999; 2:494-498.
5. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584-599.
6. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-240.
7. Zervos MJ, Hershberger E, Nicolau DP, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003; 37:1643-1648.
8. Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 2004; 39:497-503.
9. Monnet DL, MacKenzie FM, Lopez-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432-1441.
10. Bhavnani SM, Callen WA, Forrest A, et al. Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals. Am J Health Syst Pharm 2003; 60:1962-1970.
11. Bhavnani SM, Hammel JP, Jones RN, Ambrose PG. Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 2005; 51:31-37.
12. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
13. Carling PC, Fung T, Coldiron JS. Parenteral antibiotic use in acute-care hospitals: a standardized analysis of fourteen institutions. Clin Infect Dis 1999; 29:1189-1196.
14. Lesch CA, Itokazu GS, Danziger LH, Weinstein RA. Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis 2001; 41:149-154.
15. Niland JC, Rouse L, Stahl DC. An informatics blueprint for healthcare quality information systems. J Am Med Inform Assoc 2006; 13:402-417.
16. Platt R. Toward better benchmarking. Infect Control Hosp Epidemiol 2005; 26:433-434.
17. Ellis J. All inclusive benchmarking. J Nurs Manag 2006; 14:377-383.
18. Kislak JW, Eickhoff TC, Finland M. Hospital-acquired infections and antibiotic usage in the Boston city hospital - January, 1964. N Engl J Med 1964; 271:834-835.
19. Scheckler WE, Bennett JV. Antibiotic usage in seven community hospitals. JAMA 1970; 213:264-267.
20. Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm 1972; 29:828-834.
21. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978; 275:271-282.
22. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757-762.
23. Fakih MG, Hilu RC, Savoy-Moore RT, Saravolatz LD. Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs. Clin Infect Dis 2003; 37:853-856.
24. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003; 163:972-978.
25. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 2000; 133:128-135.
26. Iezzoni LI. Risk adjustment for measuring health care outcomes. 3rd ed. Chicago, IL: Health Administration Press, 2003.
27. Dellit TH, Owens RC, McGowan JE, Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159-177.
28. Pennsylvania Healthcare Cost Containment Council. Public reports. Available at: http://www.phc4.org/reports/. Accessed July 30, 2007.
29. California Office of Statewide Planning and Development, Healthcare Quality and Analysis Division. Healthcare outcomes reports. Available at: http://www.oshpd.ca.gov/HQAD/index.htm. Accessed July 30, 2007.
30. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44:664-670.
31. Hornbrook MC. Hospital case mix: its definition, measurement and use. Part I. The conceptual framework. Med Care Rev 1982; 39:1-43.
32. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118:201-210.
33. Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals. II. Analysis of patterns of use. J Infect Dis 1979; 139:698-706.
34. Janknegt R, Wijnands WJ, Caprasse M, Brandenburg W, Schuitenmaker MG, Stobberingh E. Antimicrobial drug use in hospitals in The Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993; 12:832-838.
35. McDonald LC, Yu HT, Yin HC, Hsiung CA, Hung CC, Ho M. Correlates of antibiotic use in Taiwan hospitals. Infect Control Hosp Epidemiol 2001; 22:565-571.
36. Liem TB, Filius FM, van der Linden PD, Janknegt R, Natsch S, Vulto AG. Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. Neth J Med 2005; 63:354-360.
37. Blix HS, Hartug S. Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005; 14:647-649.
38. Bhavnani SM. Benchmarking in health-system pharmacy: current re search and practical applications. Am J Health Syst Pharm 2000;57(Suppl 2):S13-S20.
39. American Hospital Association. Available at: http://www.aha.org/aha/ resource-center/Statistics-and-Studies/fast-facts.html. Accessed November 7, 2007.
40. Madaras-Kelly K. Optimizing antibiotic use in hospitals: the role of population-based antibiotic surveillance in limiting antibiotic resistance. Insights from the society of infectious diseases pharmacists. Pharmacotherapy 2003; 23:1627-1633.
41. Dalton B, Sabuda D, Conly J. Trends in antimicrobial consumption may be affected by units of measure. Clin Infect Dis 2007; 45:399-400.
42. Campbell SE, Campbell MK, Grimshaw JM, Walker AE. A systematic review of discharge coding accuracy. J Public Health Med 2001; 23:205-211.